ReViral: Biotech firm ReViral acquired by Pfizer in 412m deal
ReViral was co-founded by former Durham University lecturer Professor Stuart Cockerill and has a North East research and development facility at Sedgfield's NETPark
Read full article »
Reviral is an England-based biopharmaceutical company that develops and commercializes antiviral therapeutics for the treatment of the respiratory syncytial virus.
Read more